Mupiderm (Mupirocin Calcium)

Mupirocin calcium blocks bacterial isoleucyl‑tRNA synthetase, an enzyme essential for protein synthesis. By inhibiting this enzyme, the drug stops bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive organisms, especially Staphylococcus aureus and Streptococcus pyogenes.

The dosage of Mupiderm is determined by the prescribing healthcare professional based on the specific infection, patient age, and extent of the affected area. The prescriber will provide instructions on the amount to apply and frequency of use.

Safety data for mupirocin calcium in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the prescribing clinician.

To order Mupiderm, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mupiderm (mupirocin calcium) offers a narrow‑spectrum, high‑potency activity against Gram‑positive skin pathogens, making it especially effective for impetigo and Staphylococcus‑related infections. Compared with broader‑spectrum agents like fusidic acid, mupirocin has a lower risk of resistance development but is limited to specific indications.

Mupiderm should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and discard any product that appears discolored or contaminated.

Apply a thin layer of Mupiderm to the cleaned, dry affected skin area, usually two to three times daily as directed by the prescriber. Avoid contact with eyes, mucous membranes, and large open wounds unless specifically instructed.

Serious but rare risks include allergic contact dermatitis, severe skin irritation, anaphylaxis, and, in extremely uncommon cases, Stevens‑Johnson syndrome. Patients should discontinue use and seek medical attention if they experience widespread rash, swelling, or difficulty breathing.

Mupiderm should not be used by individuals with a known hypersensitivity to mupirocin calcium or any component of the formulation. It is also contraindicated on extensive broken skin, mucous membranes, or in patients where a systemic antibiotic is more appropriate.